A61P 5 - Drugs for disorders of the endocrine system

Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908)
11/2006
11/30/2006	US20060269613 Composition containing nanoparticles containing water-soluble basic drug encpsulated therein
11/30/2006	DE69735603T2 PTHrP Analogen PTHrP analogs
11/30/2006	CA2609726A1 17.beta.-hsd1 and sts inhibitors
11/30/2006	CA2606498A1 Novel phosphinic acid-containing thyromimetics
11/30/2006	CA2605764A1 Amorphous cinacalcet hydrochloride and preparation thereof
11/30/2006	CA2605736A1 Purification of cinacalcet
11/29/2006	EP1597276A4 Therapeutic molecules
11/29/2006	EP1259223A4 Protein matrix materials, devices and methods of making and using thereof
11/29/2006	EP1206529B1 UDP-N-ACETYLGLUCOSAMINE: GALACTOSE-BETA 1,3-N-ACETYLGALACTOSAMINE-ALPHA-R/(GlcNAc to GalNAc) BETA 1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE, C2GnT3
11/29/2006	CN1871224A 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof
11/29/2006	CN1870992A 动物饲料组合物 Animal feed compositions
11/29/2006	CN1870986A Insulin secretion potentiator
11/29/2006	CN1868458A Controlled release composition and method of producing the same
11/29/2006	CN1286815C Novel 4-anilinoquinoline-3-carboxamides compound
11/29/2006	CN1286456C Luolai compositions useful for the treatment of type-2 synalbumin diabetes pharmaceutical application
11/28/2006	US7141598 Imidazole derivatives, production method thereof and use thereof
11/28/2006	US7141580 activity as prostaglandin E2 receptor antagonists
11/28/2006	US7141558 2-ethyl and 2-ethylidene-19-nor-vitamin D compounds
11/28/2006	US7141542 Biologically active protein useful for aerosol delivery to the respiratory tract
11/28/2006	CA2379640C Certain alkylene diamine-substituted heterocycles
11/23/2006	WO2006124447A2 Substituted n-arylpyrrolidines as selective androgen receptor modulators
11/23/2006	WO2006123725A1 Pyrrolidine derivative or salt thereof
11/23/2006	WO2006122472A1 Antithyroid ointment for external use and the preparation thereof
11/23/2006	WO2006084888A3 C-terminally pegylated growth hormones
11/23/2006	WO2006076317A3 Aminophenyl derivatives as selective androgen receptor modulators
11/23/2006	US20060264434 Chemokine receptor binding heterocyclic compounds
11/23/2006	CA2608957A1 Pyrrolidine derivative or salt thereof
11/23/2006	CA2608419A1 Substituted n-arylpyrrolidines as selective androgen receptor modulators
11/22/2006	EP1724264A1 Nitriles and medicinal compositions containing the same as the active ingredient
11/22/2006	EP1722826A2 Crf receptor antagonists, their preparations, their pharmaceutical composition and their uses
11/22/2006	EP1722792A1 Selected cgrp-antagonists, method for the production and use thereof as medicaments
11/22/2006	EP1551860B1 Glucocorticoid receptor ligands for the treatment of metabolic disorders
11/22/2006	EP1467982B1 Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them, and uses thereof
11/22/2006	EP1317450B1 Pyrazole compounds useful as protein kinase inhibitors
11/22/2006	EP0970104B1 Steroid sulfamates, method for the production and use thereof
11/22/2006	CN1867559A Glutamine fructose-6-phosphate amidotransferase (GFAT) inhibitors
11/22/2006	CN1867329A (4-hydroxyphenyl)-1H-indole-3-carbaldehyde oxime derivative as estrogenic agents
11/22/2006	CN1285573C 3-desoxy-vitamin D3 analog esters
11/21/2006	US7138530 for inhibiting the enzyme C1s, a protease in the classical pathway of the complement system; and the use of this inhibition to treat or ameliorate acute or chronic disorders in mammals
11/21/2006	US7138499 antibody that binds to a peptide of given amino acid sequence related to the sulfotransferase drug-metabolizing enzyme subfamily
11/21/2006	US7138416 Compounds and therapeutic uses thereof
11/21/2006	US7138406 Antiinflammatory agents; antiallergens; vision defects; anticancer agents; gastrointestinal disorders
11/21/2006	US7138403 2,4,5-trisubstituted thiazolyl derivatives and their antiinflammatory activity
11/21/2006	US7138396 Treating androgen-dependent diseases, particularly benign prostatic hyperplasia, with a piperidinyl- or piperazinyl- N-(4-substituted pentamethylene)- or N-(4-substituted iminodiethylene)- acetamide derivative, optionally in combination with an alpha-1 adrenergic antagonist
11/21/2006	US7138392 1-[4-(2-Azepan-1-yl-ethoxy)-benzyl-2-(4-hydroxy-phenyl])-3-methyl-1H-indol-5-ol, or salts for treating bone loss
11/21/2006	US7138371 Remodeling and glycoconjugation of peptides
11/21/2006	US7138275 Dedifferentiated, programmable stem cells of monocytic origin, and their production and use
11/21/2006	US7138135 blend of anionic and nonionic water soluble hydroxyl functionalized polymer; pH insensitivity
11/21/2006	CA2272285C Amide derivatives and medicinal compositions thereof
11/16/2006	WO2006121684A2 Acyl hydrazones for treating cardiovascular diseases
11/16/2006	WO2006120575A2 Tcr-independent activation of t cells with co-lignation of cd28 and cd81
11/16/2006	WO2006119647A1 Oligonucleotides and methods of use
11/16/2006	WO2006119604A1 Method for preparing and using water-based steroid pheromone compositions
11/16/2006	WO2005077968A8 17-methylene-or 17 - spiro - cyclopropane 7 - substituted estra - 1, 3, 5 (10) - triene derivatives with anti - estrogenic activity
11/16/2006	US20060258710 Indolylalkylamino-methylidenecarbamate derivatives useful as gnrh antagonists
11/16/2006	US20060258700 7-azaindoles, their use as inhibitors of phosphodiesterase 4, and a method for synthesizing them
11/16/2006	US20060258658 Triazole compounds useful as protein kinase inhibitors
11/16/2006	US20060258575 Sustained-release microparticle preparation of human growth hormone and process for producing thereof
11/16/2006	US20060257911 Of given nucleotide sequence; diagnosis, treatment, and prevention of cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory, and metabolic disorders
11/16/2006	US20060257882 Novel polynuceotides and polypeptides encoded thereby
11/16/2006	US20060257459 Carrier
11/16/2006	US20060257427 Molecule (antibody, peptide or chemical), coupled to a detectable label, cytotoxic agent or solid support, that specifically binds an extracellular portion of the latent viral membrane bound protein of Epstein-Barr Virus expressed in the latent viral membrane in the latent life cycle
11/16/2006	CA2608243A1 Acyl hydrazones for treating cardiovascular diseases
11/15/2006	EP1721903A1 Compositions and therapeutic methods involving isoflavones and analogues thereof
11/15/2006	EP1474127B1 Biphenyl derivatives and their use as antiandrogenic agents
11/15/2006	EP1427733B1 Thieno[2,3-d]pyrimidines with combined lh and fsh agonistic activity
11/15/2006	EP1414443B1 BENZIMIDAZO 4,5-f\|ISOQUINOLINONE DERIVATIVES
11/15/2006	EP0877607B1 Biphenyl compounds and use thereof as oestrogenic agents
11/15/2006	CN1863811A Stable vitamin B6 derivative
11/15/2006	CN1861555A Triphenylalkene derivatives and their use as selective estrogen receptor modulators
11/15/2006	CN1861082A Medicine prepn. of compounding deoxypregnene contg. non-ionic surfactant
11/15/2006	CN1861077A Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
11/14/2006	US7135471 Aryl oximes
11/09/2006	WO2006117925A1 METHOD AND DEVICE FOR REGENERATING PANCREATIC β-CELLS
11/09/2006	WO2006117684A1 Methods of treating osteoporosis and secondary hyperparathyroidism using 20-methyl, gemini vitamin d3 compounds
11/09/2006	WO2006117677A1 Androgen modulators
11/09/2006	WO2006117371A1 4-PHENYL-5-0X0-l,4,5,6,7,8-HEXAHYDR0QËIN0LINE DERIVATIVES AS MEDICAMENTS FOR THE TREATMENT OF INFERTILITY
11/09/2006	WO2006117370A1 4-PHENYL-5-OXO-l,4,5,6,7,8-HEXAHYDROQUINOLINE DERIVATIVES AS MEDICAMENTS FOR THE TREATMENT OF INFERTILITY
11/09/2006	WO2006117368A1 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives the treatment of infertility
11/09/2006	WO2006117023A1 Dihydropyridine derivatives
11/09/2006	WO2006116815A1 Composition for the control of cholesterol levels
11/09/2006	WO2006116814A1 Composition and uses thereof
11/09/2006	US20060252799 Benzo (F) insoindol derivatives and their use as EP4 receptor ligands
11/09/2006	US20060251713 Amino acid sequences capable of facilitating penetration across a biological barrier
11/09/2006	CA2607150A1 Glucagon-like-peptide-2 (glp-2) analogues
11/09/2006	CA2607106A1 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives as medicaments for the treatment of infertility
11/09/2006	CA2606683A1 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives as medicaments for the treatment of infertility
11/09/2006	CA2606682A1 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives as medicaments for the treatment of infertility
11/09/2006	CA2602464A1 Methods of treating osteoporosis and secondary hyperparathyroidism using 20-methyl, gemini vitamin d3 compounds
11/08/2006	EP1361882B1 4-fluoro-n-indan-2-yl benzamide and its use as pharmaceutical
11/08/2006	EP1021190B1 Amid derivatives as growth hormone release promotors
11/08/2006	CN1857261A Aquogel type thiamazole plaster preparation
11/08/2006	CN1857195A Natural botanical hair dye
11/08/2006	CN1283656C C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases
11/08/2006	CN1283611C Novel fatty acid analogous
11/08/2006	CN1283295C Pharmaceutical composition for treating hyperthyroidism
11/07/2006	US7132560 Reacting N-methacryloyl-4-cyano-3-trifluoromethylaniline with mono-perphthalic acid to form 4-cyano-N-(2,3-epoxy-2-methylpropionyl)-3-trifluoromethylaniline
11/07/2006	US7132532 Compounds useful in the manufacture of an anti-inflammatory androstane derivative
11/07/2006	US7132436 Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1
11/07/2006	US7132417 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents

1 ... 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 ... 290